Frontlight ResearchEarly access
Sjögren's disease trials in Estonia
1 trial · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
- Where
- Tallinn
- Age
- 18 years and over
- People
- 75 worldwide
- Run by
- argenx
See details and how to joinNCT07760818 · EU 2026-526218-10-00